Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Operating Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Operating Expenses for 2 consecutive years, with $43.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 72.96% to $43.2 million in Q4 2025 year-over-year; TTM through Oct 2025 was $163.9 million, a 139.55% increase, with the full-year FY2025 number at $130.6 million, up 52.87% from a year prior.
  • Operating Expenses was $43.2 million for Q4 2025 at Kestra Medical Technologies, up from $37.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $55.8 million in Q2 2025 to a low of $20.8 million in Q1 2024.